Tag Archive for: SOTIO

Biocytogen Co Ltd
ADC

SOTIO partners with Biocytogen to expand ADC pipeline

Czech Sotio Biotech has inked an R&D and licence option agreement with Chinese antibody maker Biocytogen.

Read more
partnership

SOTIO licences first cancer ADC from LegoChem Biosciences

SOTIO Biotech a.s. has exercised its first of five exclusive, target-specific options for antibody-drug conjugate (ADC) SOT106 under its agreement with LegoChem Biosciences Inc.

Read more